Carnitine transporter CT2 (SLC22A16) is over-expressed in acute myeloid leukemia (AML) and target knockdown reduces growth and viability of AML cells
Research progress Support The animal experiments have achieved remarkable results: In the obese mouse model, after daily subcutaneous injection of AOD 9604 (250 g/kg) for 8 weeks, the body weight of the mice decreased by 12%, the subcutaneous fat mass decreased by 25%, and the weight of epididymal adipose tissue significantly decreased, confirming its effectiveness in fat reduction
The experiment was designed with three levels of dietary energy (low, medium and high) and two levels of L-carnitine (0 and 100 mg/kg diet) in a 3x2 factorial arrangement
Cramping Some users report that supplementing with glutathione causes stomach pain and cite that this symptom is usually worse during the first few days using the supplement (x)
Fang X, Wang K, Han D, et al
Do not inject two doses within 3 days of each other